Resource

NRAS support new COVID-19 vaccination effects study in India

COVID-19 Vaccination in Autoimmune Disease (CoVAD) study

Print

Many countries are actively vaccinating their population against Covid-19 infection, after large clinical trials showed effectiveness and safety of the vaccine. However, the data on effects of the vaccine in patients with autoimmune disease are lacking.

Dr. Latika Gupta (Principal Investigator) and Sanjay Gandhi from the Postgraduate Institute of Medical Sciences in Luknow, India are amongst a group of scientists and doctors who are conducting the above study to look at the effects of COVID-19 vaccine in patients with autoimmune diseases by comparison to healthy individuals. They want to hear from people with autoimmune diseases like Rheumatoid Arthritis as well as those who do not have autoimmune disease, so any family members of people with RA who do not have an autoimmune condition are invited to take part in the survey too.

NRAS is supporting this work and the survey takes approx. 5-10 mins. to complete. All responses will be kept confidential and anonymous in line with GDPR and study protocols. Data from the study will be analysed and published in a peer reviewed medical journal where the long term effects of the COVID-19 vaccine will be discussed. The survey will be running until the end of August.